Browsing Tag
Pharma acquisition news
231 posts
Thermo Fisher to acquire clinical research services provider PPD for $21bn
Thermo Fisher Scientific has agreed to acquire PPD, a US-based clinical research services provider, for $47.50 per share…
April 16, 2021
Merck wraps up $1.8bn acquisition of Pandion Therapeutics
Merck has wrapped up its previously announced $1.85 billion acquisition of Massachusetts-based clinical-stage biotech company Pandion Therapeutics. The…
April 11, 2021
Amgen to acquire Rodeo Therapeutics in $721m worth deal
Amgen has agreed to acquire Rodeo Therapeutics, a Seattle-based biopharma company, in a deal worth up to $721…
March 31, 2021
Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab
Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech…
March 4, 2021
Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn
Altaris Capital Partners has agreed to acquire the prescription pharma (Rx) business of Perrigo Company plc, an Ireland-based…
March 2, 2021
Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities
Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450…
February 26, 2021
Merck to acquire US biotech company Pandion Therapeutics for $1.8bn
Merck has agreed to acquire Pandion Therapeutics, a Massachusetts-based clinical-stage biotech company, for about $1.85 billion in an…
February 25, 2021
Eurofins Scientific to acquire Beacon Discovery to expand drug discovery capabilities
Eurofins Scientific, a testing laboratories company based in Luxembourg, has agreed to acquire Beacon Discovery, a drug discovery…
February 18, 2021
Humacyte to merge with Alpha Healthcare Acquisition Corp in $1.1bn deal to advance regenerative medicine
Humacyte, Inc., a clinical-stage biotech company based in Durham, North Carolina, has announced a merger with Alpha Healthcare…
February 17, 2021
Sandoz to acquire GSK’s cephalosporin antibiotics business for $500m
Sandoz, a division of the Swiss pharmaceutical giant Novartis, has finalized a deal to acquire the cephalosporin antibiotics…
February 13, 2021